- PKR to file Balik Pulau petition
- Mom stabs 2-year old girl in head with scissors during tiff with hubby
- M'sian couple on Aussie rich list
- Police capable of handling gathering in PJ - Ahmad Zahid
- Stone Temple Pilots sue ex-frontman Scott Weiland
- 'Only two solutions to avert disaster'
- Soccer: I got carried away with QPR, says ’naive’ Fernandes
- Paul Low resigns as Transparency International Malaysia president
- University lecturers to boost English in schools
- Opposition agreed to hold peaceful gatherings but did opposite - Zahid
- Police will appeal rejection of remand on trio, says Ahmad Zahid
- Malaysian couple joins Aussie's billionaire club
- 2 coaches leave Manchester United
- Giant Lego Star Wars X-Wing lands on NY's Times Square
- Thousands throng temples nationwide More
• Neurofibromatosis (NF) is a disorder of the nervous system. NF is divided into three distinct subtypes — NF1, NF2 and Schwannomatosis. All three subtypes are clinically and genetically distinct. However, the three subtypes share an overlapping feature — benign tumours that grow on nerves.
• NF2 is a genetic defect or a mutation (change) in a single gene located on chromosome 22. The defect is caused by an error in the process of copying genetic information and not caused by anything under a person’s control. It causes benign tumours to grow on the central and peripheral nervous system which includes the brain, spine and all other nerves.
• NF2 is either inherited from affected parent(s) or results from a spontaneous mutation — in which case there is no prior history of NF2.
• Nearly all those with NF2 develop vestibular schwannomas or tumours that grow on the hearing nerves (called the eight cranial nerve). The eight cranial nerve consists of two portions — the vestibular (balance) nerve and acoustic (hearing) nerve. Tumours that develop on the eight cranial nerve cause symptoms of hearing loss, ringing in the ears (tinnitus) and balance issues.
• The age of onset and progression of NF2 varies from individual to individual. Most people diagnosed with NF2 become symptomatic in their late teens or early 20’s. However, some individuals may develop symptoms
in their early childhood or as late as their 40’s or 50’s.
• There is currently no cure for NF2. Treatment options include surgery, radiation therapy and more recently, experimental chemotherapy. Clinical trials are ongoing for a number of drugs which aim to destroy the blood supply of NF2-related tumours.
source : www.ctf.org
